Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2687-2689

  Besada, Emilio ^a   Njålla, Rune Johan ^b   Nossent, Johannes C ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Hospital of Nordland   (Norway)

Author keywords

Etanercept; Inhibitors; Opportunistic infection; Psoriasis arthritis; Tumor necrosis factor alpha; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; ETANERCEPT; IMMUNOGLOBULIN G; METHOTREXATE;

ANTIMICROBIAL THERAPY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILL; DISEASE ACTIVITY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOPHENOTYPING; LEISHMANIA DONOVANI; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MEAN CORPUSCULAR VOLUME; NEUTROPHIL COUNT; NIGHT SWEAT; NORWAY; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SPAIN; SPLENOMEGALY; THROMBOCYTE COUNT; VISCERAL LEISHMANIASIS;

AGED; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; LEISHMANIASIS, VISCERAL; METHOTREXATE; NORWAY; PANCYTOPENIA; RECEPTORS, TUMOR NECROSIS FACTOR; SPAIN; TREATMENT OUTCOME;

EID: 84885380681     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2483-4     Document Type: Article

References (14)

1. Ready PD (2010) Leishmaniasis emergence in Europe. Euro Surveill 15(10):19505
2. Moral L, Rubio EM, Moya M (2002) A leishmanin skin test survey in the human population of l'Alacantí region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Trans R Soc Trop Med Hyg 96:129-132
3. Marty P, Izri A, Ozon C, Haas P, Rosenthal E, Del Giudice P et al (2007) A century of leishmaniasis in Alpes-Maritimes, France. Ann Trop Med Parasitol 101:563-574
4. Erre GL, Mesina P, Tonelli N, Passiu G (2010) Visceral leishmaniasis among immunosuppressed patients with rheumatic diseases. Clin Exp Rheumatol 28:590-591
5. Marty P, Pomares-Estran C, Hasseine L, Delaunay P, Haas H, Rosenthal E (2009) Leishmaniasis in France: an update. Arch Pediatr 16(Suppl 2):S96-S100
6. Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV (2009) Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerg Infect Dis 15:956-959
7. Malik ANJ, John L, Bryceson ADM, Lockwood DNJ (2006) Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerg Infect Dis 12:1257-1259
8. De Leonardis F, Govoni M, Lo Monaco A, Trotta F (2009) Visceral leishmaniasis and anti-TNF-α therapy: case report and literature review. Clin Exp Rheumatol 27:503-506
9. Sakkas LI, Boulbou M, Kyriakou D, Makri I, Sinani C, Germenis A et al (2008) Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem 41:65-68
10. Castellino G, Govoni M, Lo Monaco A, Montecucco C, Colombo F, Trotta F (2004) Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy. Lupus 13:201-203
11. Viana RB, Neiva CL, Dias AF, do Rosario e Souza EF, de Padua PM (2010) Felty's syndrome and Kala-azar: a challenge for the rheumatologist. Rev Bras Rheumatol 50:710-715
12. Ahlin E, Elshafei A, Nur M, El Safi SH, Ronnelid J, Elghazali G (2011) Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania Donovani infection. Rev Bras Reumatol 51:572-586
13. Rizos E, Dimos G, Liberopoulos EN, Elisaf MS, Drosos AA (2005) Cryoglobulinemic purpura in visceral leishmaniasis. Rheumatol Int 25:469-471
14. Skram MK, Bjering S, Hermansen NO, Dini L, Hellebostad M (2011) En 15 gammel måneder jenta med feber og pancytopeni. Tidsskr Nor Legeforen 31:2482-2486